Related Experiment Video
Updated: Jun 25, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Neuropsychologic status at the age 4 years and atopy in a population-based birth cohort
Insights
Children's early neurodevelopment may predict allergy risk. Lower cognitive and social scores in preschoolers were linked to a higher likelihood of developing atopy (allergic disease) by age six.
Area of Science:
- Pediatric Allergy and Immunology
- Developmental Psychology
- Neuroscience
Background:
- Existing research suggests a link between mental health and allergies.
- However, limited cohort studies have explored neurodevelopment as a predictor of atopy.
Purpose of the Study:
- To examine the association between neurobehavioral status in 4-year-old children and specific immunoglobulin E (IgE) levels.
- To assess the relationship with skin prick test results at age six.
Main Methods:
- A population-based birth cohort of 482 children was utilized.
- Neurobehavioral data, specific IgE levels at age 4, and skin prick tests at age 6 were collected.
- Atopy was defined by elevated IgE or positive skin prick tests.
Main Results:
- Atopy prevalence was 12% at age 4 and 17% at age 6.
- Lower neurobehavioral scores (general cognitive, verbal, executive function, social competence) were associated with increased risk of atopy at age 6.
- Childhood allergic diseases (asthma, eczema, etc.) at age 6 correlated with earlier neurodevelopmental status.
Conclusions:
- Preschool-age neuropsychological functioning is negatively associated with the development of atopy later in childhood.
- Early neurodevelopmental assessments may offer insights into future allergy risk.
Background:
Mental health has been reported to be associated with allergy, but only a few cohort studies have assessed if neurodevelopment predicts atopy.
Objective:
To investigate if neurobehavioral status of healthy 4-year-old children was associated with specific immunoglobulin E (IgE) at the same age and skin prick test results 2 years later.
Methods:
A population-based birth cohort enrolled 482 children, 422 of them (87%) provided neurobehavioral data, 341 (71%) had specific IgE measured at the age of 4 years; and 395 (82%) had skin prick tests completed at the age of 6 years. Atopy was defined as IgE levels higher than 0.35 kU/l to any of the three tested allergens at the age of 4 or as a positive skin prick test to any of the six tested allergens at the age of 6. McCarthy Scales of Child Abilities and California Preschool Social Competence Scale were the psychometric instruments used.
Results:
Twelve percent of children at the age of 4 and 17% at the age of 6 were atopic. Neurobehavioral scores were negatively associated with 6-year-old atopy after adjustment for socio-demographic and allergic factors, A relative risk of 3.06 (95% CI: 1.30-7.24) was associated with the lowest tertile (scorings < or =90 points) of the general cognitive scale. Similar results were found for verbal abilities, executive functions, and social competence. Asthma, wheezing, rhinitis, and eczema at the age of 6, but not at the age of 4, were associated with neurodevelopment at the age of 4.
Conclusions:
Neuropsychologic functioning and later atopy are negatively associated in preschool age children.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Asthma I: Introduction
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations

